Retrieve available abstracts of 252 articles: HTML format
Single Articles
May 2025
KOUTSAKOS M, Reynaldi A, Aban M, Barr IG, et al Binding antibody titers against the hemagglutinin and neuraminidase correlate
with protection against medically attended influenza A and B disease.
J Virol. 2025 May 13:e0039125. doi: 10.1128/jvi.00391. PubMedAbstract available
XIE Z, Yang J, Jiao W, Li X, et al Clade 2.3.4.4b highly pathogenic avian influenza H5N1 viruses: knowns, unknowns,
and challenges.
J Virol. 2025 May 9:e0042425. doi: 10.1128/jvi.00424. PubMedAbstract available
LI Y, Quan X, Chen R, Wang X, et al Adaptive selection of quasispecies during in vivo passaging in chickens, mice,
and ferrets results in host-specific strains for the H9N2 avian influenza virus.
J Virol. 2025 May 8:e0015125. doi: 10.1128/jvi.00151. PubMedAbstract available
April 2025
LE CTT, Kim K-H, Raha JR, Bhatnagar N, et al Dual roles of influenza B virus neuraminidase mRNA vaccine in enhancing
cross-lineage protection by supplementing inactivated split vaccination.
J Virol. 2025 Apr 23:e0229424. doi: 10.1128/jvi.02294. PubMedAbstract available
LOWEN AC, Baker AL, Bowman AS, Garcia-Sastre A, et al Pandemic risk stemming from the bovine H5N1 outbreak: an account of the knowns
and unknowns.
J Virol. 2025;99:e0005225. PubMedAbstract available
ADU OF, Sempere Borau M, Fruh SP, Karakus U, et al Cell binding, uptake, and infection of influenza A virus using recombinant
antibody-based receptors.
J Virol. 2025 Apr 10:e0227524. doi: 10.1128/jvi.02275. PubMedAbstract available
XU S, Liu Y, Luo C, Zhou M, et al Identification and characterization of a broadly neutralizing and protective
nanobody against the HA1 domain of H5 avian influenza virus hemagglutinin.
J Virol. 2025 Apr 7:e0209024. doi: 10.1128/jvi.02090. PubMedAbstract available
XIAO X, Wang X, Xu F, Liang Y, et al Synergistic effects of PA (S184N) and PB2 (E627K) mutations on the increased
pathogenicity of H3N2 canine influenza virus infections in mice and dogs.
J Virol. 2025 Apr 4:e0198424. doi: 10.1128/jvi.01984. PubMedAbstract available
March 2025
KRAMMER F, Hermann E, Rasmussen AL Highly pathogenic avian influenza H5N1: history, current situation, and outlook.
J Virol. 2025 Mar 27:e0220924. doi: 10.1128/jvi.02209. PubMedAbstract available
YU L, Jiang Y, Rang H, Wang X, et al Restriction of influenza A virus replication by host DCAF7-CRL4B axis.
J Virol. 2025 Mar 27:e0013325. doi: 10.1128/jvi.00133. PubMedAbstract available
JANA ID, Kanjo K, Roy S, Bhasin M, et al Early 2022 breakthrough infection sera from India target the conserved cryptic
class 5 epitope to counteract immune escape by SARS-CoV-2 variants.
J Virol. 2025 Mar 26:e0005125. doi: 10.1128/jvi.00051. PubMedAbstract available
LI P, Faraone JN, Hsu CC, Chamblee M, et al Role of glycosylation mutations at the N-terminal domain of SARS-CoV-2 XEC
variant in immune evasion, cell-cell fusion, and spike stability.
J Virol. 2025 Mar 26:e0024225. doi: 10.1128/jvi.00242. PubMedAbstract available
LANG Y, Shi L, Roy S, Gupta D, et al Detection of antibodies against influenza A viruses in cattle.
J Virol. 2025 Mar 25:e0213824. doi: 10.1128/jvi.02138. PubMedAbstract available
JOHN K, Huntress I, Smith E, Chou H, et al Human long noncoding RNA VILMIR is induced by major respiratory viral infections
and modulates the host interferon response.
J Virol. 2025 Mar 25:e0014125. doi: 10.1128/jvi.00141. PubMedAbstract available
DADONAITE B, Burrell AR, Logue J, Chu HY, et al SARS-CoV-2 neutralizing antibody specificities differ dramatically between
recently infected infants and immune-imprinted individuals.
J Virol. 2025 Mar 25:e0010925. doi: 10.1128/jvi.00109. PubMedAbstract available
BEAVIS AC, Xiao P, Gingerich MC, Briggs K, et al A parainfluenza virus 5 (PIV5)-vectored intranasal SARS-CoV-2 vaccine (CVXGA1)
elicits protective and long-lasting immunity in nonhuman primates.
J Virol. 2025 Mar 21:e0199024. doi: 10.1128/jvi.01990. PubMedAbstract available
BEAVIS AC, Li Z, Briggs K, Gingerich MC, et al Efficacy of parainfluenza virus 5 (PIV5)-vectored intranasal COVID-19 vaccine as
a single dose primer and booster against SARS-CoV-2 variants.
J Virol. 2025 Mar 21:e0198924. doi: 10.1128/jvi.01989. PubMedAbstract available
SIMS A, Weir DJ, Cole SJ, Hutchinson E, et al SARS-CoV-2 cellular coinfection is limited by superinfection exclusion.
J Virol. 2025 Mar 21:e0207724. doi: 10.1128/jvi.02077. PubMedAbstract available
HU H, Zhang Y, Zheng H, Zhao X, et al Thymic stromal lymphopoietin improves protective immunity of the SARS-CoV-2
subunit vaccine by inducing dendritic cell-dependent germinal center response.
J Virol. 2025 Mar 4:e0232324. doi: 10.1128/jvi.02323. PubMedAbstract available
KARL V, Hofmann M, Thimme R Role of antiviral CD8+ T cell immunity to SARS-CoV-2 infection and vaccination.
J Virol. 2025 Mar 3:e0135024. doi: 10.1128/jvi.01350. PubMedAbstract available
February 2025
QU X, Zhu Z, Zhou X, Wu X, et al KRT9 is required for GBP5 suppression of human respiratory syncytial virus.
J Virol. 2025;99:e0202924. PubMedAbstract available
MILLER JL, Leedale C, Kang D, Lilue J, et al Prostaglandin D2 delays CD8+ T-cell responses and respiratory syncytial virus
clearance in geriatric cotton rats.
J Virol. 2025;99:e0186324. PubMedAbstract available
HAO T, Xie Y, Chai Y, Zhang W, et al Structural basis of receptor-binding adaptation of human-infecting H3N8 influenza
A virus.
J Virol. 2025 Feb 24:e0106524. doi: 10.1128/jvi.01065. PubMedAbstract available
KOBAYASHI D, Hiono T, Arakawa H, Kaji H, et al Deglycosylation and truncation in the neuraminidase stalk are functionally
equivalent in enhancing the pathogenicity of a high pathogenicity avian influenza
virus in chickens.
J Virol. 2025 Feb 14:e0147824. doi: 10.1128/jvi.01478. PubMedAbstract available
MA R, Zhang X, Li R, Dong X, et al PLSCR1 suppresses SARS-CoV-2 infection by downregulating cell surface ACE2.
J Virol. 2025 Feb 13:e0208524. doi: 10.1128/jvi.02085. PubMedAbstract available
FURUSAWA Y, Kiso M, Uraki R, Sakai-Tagawa Y, et al Amino acid substitutions in NSP6 and NSP13 of SARS-CoV-2 contribute to superior
virus growth at low temperatures.
J Virol. 2025 Feb 12:e0221724. doi: 10.1128/jvi.02217. PubMedAbstract available
KUHN AJ, Outlaw VK, Marcink TC, Yu Z, et al Enhancing the solubility of SARS-CoV-2 inhibitors to increase future prospects
for clinical development.
J Virol. 2025 Feb 4:e0215924. doi: 10.1128/jvi.02159. PubMedAbstract available
PHAN T, Ribeiro RM, Edelstein GE, Boucau J, et al Modeling suggests SARS-CoV-2 rebound after nirmatrelvir-ritonavir treatment is
driven by target cell preservation coupled with incomplete viral clearance.
J Virol. 2025 Feb 4:e0162324. doi: 10.1128/jvi.01623. PubMedAbstract available
WANG X, Dong M, Wu X, Schnepf D, et al Single-cell transcriptomics reveals a compartmentalized antiviral interferon
response in the nasal epithelium of mice.
J Virol. 2025 Feb 4:e0141324. doi: 10.1128/jvi.01413. PubMedAbstract available
PARK H, Kingstad-Bakke B, Cleven T, Jung M, et al Diversifying T-cell responses: safeguarding against pandemic influenza with
mosaic nucleoprotein.
J Virol. 2025 Feb 3:e0086724. doi: 10.1128/jvi.00867. PubMedAbstract available
January 2025
KIRKPATRICK ROUBIDOUX E, Meliopoulos V, Livingston B, Brigleb PH, et al Intraductal infection with H5N1 clade 2.3.4.4b influenza virus.
J Virol. 2025 Jan 31:e0192724. doi: 10.1128/jvi.01927. PubMed
ZHAO B, Sun Z, Wang S, Shi Z, et al Structural basis of different neutralization capabilities of monoclonal
antibodies against H7N9 virus.
J Virol. 2025;99:e0140024. PubMedAbstract available
SAMAAN P, Korosec CS, Budylowski P, Chau SLL, et al mRNA vaccine-induced SARS-CoV-2 spike-specific IFN-gamma and IL-2 T-cell responses
are predictive of serological neutralization and are transiently enhanced by
pre-existing cross-reactive immunity.
J Virol. 2025 Jan 31:e0168524. doi: 10.1128/jvi.01685. PubMedAbstract available
LYTRAS S, Lamb KD, Ito J, Grove J, et al Pathogen genomic surveillance and the AI revolution.
J Virol. 2025 Jan 29:e0160124. doi: 10.1128/jvi.01601. PubMedAbstract available
WANG Y, Xia B, Gao Z A comprehensive review of current insights into the virulence factors of
SARS-CoV-2.
J Virol. 2025 Jan 29:e0204924. doi: 10.1128/jvi.02049. PubMedAbstract available
SADLER HL, Rijal P, Tan TK, Townsend ARM, et al A locally administered single-cycle influenza vaccine expressing a non-fusogenic
stabilized hemagglutinin stimulates strong T-cell and neutralizing antibody
immunity.
J Virol. 2025 Jan 27:e0033124. doi: 10.1128/jvi.00331. PubMedAbstract available
FOO IJH, Chua BY, Chang SY, Jia X, et al Prior influenza virus infection alleviates an arbovirus encephalitis by reducing
viral titer, inflammation, and cellular infiltrates in the central nervous
system.
J Virol. 2025 Jan 16:e0210824. doi: 10.1128/jvi.02108. PubMedAbstract available
NAGHIBOSADAT M, Babuadze GG, Pei Y, Hurst J, et al Vaccination against SARS-CoV-2 provides low-level cross-protection against common
cold coronaviruses in mouse and non-human primate animal models.
J Virol. 2025 Jan 16:e0139024. doi: 10.1128/jvi.01390. PubMedAbstract available
CAI C, Pham TNQ, Adam D, Brochiero E, et al Sensing of SARS-CoV-2-infected cells by plasmacytoid dendritic cells is modulated
via an interplay between CD54/ICAM-1 and CD11a/LFA-1 alpha(L) integrin.
J Virol. 2025 Jan 13:e0123524. doi: 10.1128/jvi.01235. PubMedAbstract available
PERRY SS, Brice DC, Sakr AA, Kandeil A, et al Modulation of cytokeratin and cytokine/chemokine expression following influenza
virus infection of differentiated human tonsillar epithelial cells.
J Virol. 2025 Jan 10:e0146024. doi: 10.1128/jvi.01460. PubMedAbstract available
FOX CR, Yousef NN, Varudkar N, Shiffer EM, et al Resistance to complement-mediated lysis of parainfluenza virus 5-infected cells
is acquired after transition from acute to persistent infection.
J Virol. 2025 Jan 10:e0189524. doi: 10.1128/jvi.01895. PubMedAbstract available
ARORA P, Zhang L, Nehlmeier I, Kempf A, et al Host cell lectins ASGR1 and DC-SIGN jointly with TMEM106B confer ACE2
independence and imdevimab resistance to SARS-CoV-2 pseudovirus with spike
mutation E484D.
J Virol. 2025 Jan 10:e0123024. doi: 10.1128/jvi.01230. PubMedAbstract available
HU H, Leng C, Shu Y, Peng L, et al Structural insights into hybridoma-derived neutralizing monoclonal antibodies
against Omicron BA.5 and XBB.1.16 variants of SARS-CoV-2.
J Virol. 2025 Jan 7:e0130724. doi: 10.1128/jvi.01307. PubMedAbstract available
GUNAWARDENE CD, Wong L-YR Betacoronavirus internal protein: role in immune evasion and viral pathogenesis.
J Virol. 2025 Jan 6:e0135324. doi: 10.1128/jvi.01353. PubMedAbstract available
December 2024
CAI Z, Ni W, Li W, Wu Z, et al SARS-CoV-2 S protein disrupts the formation of ISGF3 complex through conserved S2
subunit to antagonize type I interferon response.
J Virol. 2024 Dec 19:e0151624. doi: 10.1128/jvi.01516. PubMedAbstract available
XIONG Y, Tao K, Li T, Zhou Y, et al Both chebulagic acid and punicalagin inhibit respiratory syncytial virus entry
via multi-targeting glycoprotein and fusion protein.
J Virol. 2024;98:e0153624. PubMedAbstract available
NEAL HE, Barrett CT, Edmonds K, Moncman CL, et al Examination of respiratory syncytial virus fusion protein proteolytic processing
and roles of the P27 domain.
J Virol. 2024;98:e0163924. PubMedAbstract available
TAKAHASHI T, Amarbayasgalan S, Ueno S, Sugiura Y, et al Lethal model for respiratory syncytial virus infection using C57BL/6 mice.
J Virol. 2024;98:e0177224. PubMedAbstract available
LV H, Teo QW, Lee C-CD, Liang W, et al Differential antigenic imprinting effects between influenza H1N1 hemagglutinin
and neuraminidase in a mouse model.
J Virol. 2024 Dec 5:e0169524. doi: 10.1128/jvi.01695. PubMedAbstract available
YANG K, Nizami S, Hu S, Zou L, et al Genetic diversity of highly pathogenic avian influenza H5N6 and H5N8 viruses in
poultry markets in Guangdong, China, 2020-2022.
J Virol. 2024 Dec 4:e0114524. doi: 10.1128/jvi.01145. PubMedAbstract available
November 2024
KAKIZAKI M, Hashimoto R, Nagata N, Yamamoto T, et al The respective roles of TMPRSS2 and cathepsins for SARS-CoV-2 infection in human
respiratory organoids.
J Virol. 2024 Nov 27:e0185324. doi: 10.1128/jvi.01853. PubMedAbstract available
SHETTY N, Shephard MJ, Rockey NC, Macenczak H, et al Influenza virus infection and aerosol shedding kinetics in a controlled human
infection model.
J Virol. 2024 Nov 26:e0161224. doi: 10.1128/jvi.01612. PubMedAbstract available
FUJIMOTO Y, Ozaki K, Ono E Chicken ANP32A-independent replication of highly pathogenic avian influenza
viruses potentially leads to mammalian adaptation-related amino acid
substitutions in viral PB2 and PA proteins.
J Virol. 2024 Nov 21:e0184024. doi: 10.1128/jvi.01840. PubMedAbstract available
BOLLAND W, Marechal I, Petiot C, Porrot F, et al SARS-CoV-2 entry and fusion are independent of ACE2 localization to lipid rafts.
J Virol. 2024 Nov 21:e0182324. doi: 10.1128/jvi.01823. PubMedAbstract available
PATINO-GALINDO J, Garcia-Sastre A, Kuhn JH, Rabadan R, et al Recombination across distant coronavirid species and genera is a rare event with
distinct genomic features.
J Virol. 2024 Nov 19:e0110024. doi: 10.1128/jvi.01100. PubMedAbstract available
LI C, Culhane MR, Schroeder DC, Cheeran MC-J, et al Quantifying the impact of vaccination on transmission and diversity of influenza
A variants in pigs.
J Virol. 2024 Nov 12:e0124524. doi: 10.1128/jvi.01245. PubMedAbstract available
POWELL JD, Thomas MN, Anderson TK, Zeller MA, et al 2018-2019 human seasonal H3N2 influenza A virus spillovers into swine with
demonstrated virus transmission in pigs were not sustained in the pig population.
J Virol. 2024 Nov 11:e0008724. doi: 10.1128/jvi.00087. PubMedAbstract available
CHEN D, Zhang W, Xiao B, Xu B, et al Effect of wild-type vaccine doses on BA.5 hybrid immunity, disease severity, and
XBB reinfection risk.
J Virol. 2024 Nov 5:e0128524. doi: 10.1128/jvi.01285. PubMedAbstract available
SUN X, Belser JA, Pulit-Penaloza JA, Brock N, et al Dissecting the role of the HA1-226 leucine residue in the fitness and airborne
transmission of an A(H9N2) avian influenza virus.
J Virol. 2024 Nov 4:e0092824. doi: 10.1128/jvi.00928. PubMedAbstract available
STEIN SC, Hansen G, Ssebyatika G, Stroh LJ, et al A human monoclonal antibody neutralizing SARS-CoV-2 Omicron variants containing
the L452R mutation.
J Virol. 2024 Nov 4:e0122324. doi: 10.1128/jvi.01223. PubMedAbstract available
PARRY RH, Lytras S, Petrone ME, Wille M, et al No evidence that mutations in SARS-CoV-2 variants of concern derive from
homologous fragments in gut microbiota.
J Virol. 2024 Nov 4:e0146824. doi: 10.1128/jvi.01468. PubMedAbstract available
October 2024
ZHANG C, Jiang Q, Liu Z, Li N, et al SARS-CoV-2 NSP6 reduces autophagosome size and affects viral replication via
sigma-1 receptor.
J Virol. 2024 Oct 24:e0075424. doi: 10.1128/jvi.00754. PubMedAbstract available
SHAHRIARI S, Ghildyal R The actin-binding protein palladin associates with the respiratory syncytial
virus matrix protein.
J Virol. 2024;98:e0143524. PubMedAbstract available
FAURE-DUPUY S, Depierre M, Fremont-Debaene Z, Herit F, et al Human rhinovirus 16 induces an ICAM-1-PKR-ATF2 axis to modulate macrophage
functions.
J Virol. 2024;98:e0149924. PubMedAbstract available
HAN Y, Zhou H, Liu C, Wang W, et al SARS-CoV-2 N protein coordinates viral particle assembly through multiple
domains.
J Virol. 2024 Oct 16:e0103624. doi: 10.1128/jvi.01036. PubMedAbstract available
TRIMARCO JD, Spurrier MA, Skavicus S, Luo Z, et al Fluorescent and bioluminescent bovine H5N1 influenza viruses for evaluation of
antiviral interventions.
J Virol. 2024 Oct 10:e0138524. doi: 10.1128/jvi.01385. PubMedAbstract available
LI A, Zhao K, Duan Y, Zhang B, et al SARS-CoV-2 nsp13 suppresses hepatitis B virus replication by targeting cccDNA
transcription.
J Virol. 2024 Oct 7:e0104224. doi: 10.1128/jvi.01042. PubMedAbstract available
WANG W, Bhushan G, Paz S, Stauft CB, et al Human and hamster sera correlate well in identifying antigenic drift among
SARS-CoV-2 variants, including JN.1.
J Virol. 2024 Oct 4:e0094824. doi: 10.1128/jvi.00948. PubMedAbstract available
DO THT, Wille M, Wheatley AK, Koutsakos M, et al Triton X-100-treated virus-based ELLA demonstrates discordant antigenic evolution
of influenza B virus hemagglutinin and neuraminidase.
J Virol. 2024 Oct 3:e0118624. doi: 10.1128/jvi.01186. PubMedAbstract available
September 2024
HAMELE CE, Luo Z, Leonard RA, Spurrier MA, et al Headless hemagglutinin-containing influenza viral particles direct immune
responses toward more conserved epitopes.
J Virol. 2024 Sep 26:e0116624. doi: 10.1128/jvi.01166. PubMedAbstract available
LOES AN, Tarabi RAL, Huddleston J, Touyon L, et al High-throughput sequencing-based neutralization assay reveals how repeated
vaccinations impact titers to recent human H1N1 influenza strains.
J Virol. 2024 Sep 24:e0068924. doi: 10.1128/jvi.00689. PubMedAbstract available
DAVID SC, Schaub A, Terrettaz C, Motos G, et al Correction for David et al., "Stability of influenza A virus in droplets and
aerosols is heightened by the presence of commensal respiratory bacteria".
J Virol. 2024 Sep 19:e0122224. doi: 10.1128/jvi.01222. PubMed
WANG Z, Qiu M, Ji Y, Chai K, et al Palmitoylation of SARS-CoV-2 Envelope protein is central to virus particle
formation.
J Virol. 2024 Sep 17:e0107224. doi: 10.1128/jvi.01072. PubMedAbstract available
BROOKS K, Nelson CE, Aguilar C, Hoang TN, et al SARS-CoV-2 infection perturbs the gastrointestinal tract and induces modest
microbial translocation across the intestinal barrier.
J Virol. 2024 Sep 12:e0128824. doi: 10.1128/jvi.01288. PubMedAbstract available
HAN M, Lu Q, Wang D, Zhou K, et al Oral co-administration of Lactiplantibacillus plantarum 16 and Lacticaseibacillus
rhamnosus P118 improves host defense against influenza A virus infection.
J Virol. 2024 Sep 11:e0095024. doi: 10.1128/jvi.00950. PubMedAbstract available
SOUDANI N, Bricker TL, Darling T, Seehra K, et al Immunogenicity and efficacy of XBB.1.5 rS vaccine against the EG.5.1 variant of
SARS-CoV-2 in Syrian hamsters.
J Virol. 2024 Sep 4:e0052824. doi: 10.1128/jvi.00528. PubMedAbstract available
GUAN M, DeLiberto TJ, Feng A, Zhang J, et al Neu5Gc binding loss of subtype H7 influenza A virus facilitates adaptation to
gallinaceous poultry following transmission from waterbirds.
J Virol. 2024 Sep 3:e0011924. doi: 10.1128/jvi.00119. PubMedAbstract available
August 2024
YANG Y, Xu C, Zhang N, Wan Y, et al Two amino acid residues in the N-terminal region of the polymerase acidic protein
determine the virulence of Eurasian avian-like H1N1 swine influenza viruses in
mice.
J Virol. 2024 Aug 30:e0129324. doi: 10.1128/jvi.01293. PubMedAbstract available
BARRETO-DURAN E, Synowiec A, Szczepanski A, Galuszka-Bulaga A, et al Development of an intestinal mucosa ex vivo co-culture model to study viral
infections.
J Virol. 2024 Aug 30:e0098724. doi: 10.1128/jvi.00987. PubMedAbstract available
HU Y, Jin Y, Han D, Zhang G, et al Correction for Hu et al., "Mast Cell-Induced Lung Injury in Mice Infected with
H5N1 Influenza Virus".
J Virol. 2024 Aug 29:e0110624. doi: 10.1128/jvi.01106. PubMed
ALFADHLI A, Bates TA, Barklis RL, Romanaggi C, et al A nanobody interaction with SARS-COV-2 Spike allows the versatile targeting of
lentivirus vectors.
J Virol. 2024 Aug 29:e0079524. doi: 10.1128/jvi.00795. PubMedAbstract available
DMYTRENKO O, Das S, Kovacs A, Cicka M, et al Infiltrating monocytes drive cardiac dysfunction in a cardiomyocyte-restricted
mouse model of SARS-CoV-2 infection.
J Virol. 2024 Aug 29:e0117924. doi: 10.1128/jvi.01179. PubMedAbstract available
LIEBER CM, Kang H-J, Sobolik EB, Sticher ZM, et al Efficacy of late-onset antiviral treatment in immunocompromised hosts with
persistent SARS-CoV-2 infection.
J Virol. 2024 Aug 29:e0090524. doi: 10.1128/jvi.00905. PubMedAbstract available
GOODWIN E, Gibbs JS, Yewdell JW, Eisenlohr LC, et al Influenza virus antibodies inhibit antigen-specific de novo B cell responses in
mice.
J Virol. 2024 Aug 28:e0076624. doi: 10.1128/jvi.00766. PubMedAbstract available
HARTWIG SM, Odle A, Wong L-YR, Meyerholz DK, et al Respiratory syncytial virus infection provides protection against severe acute
respiratory syndrome coronavirus challenge.
J Virol. 2024 Aug 28:e0066924. doi: 10.1128/jvi.00669. PubMedAbstract available
YING B, Liang C-Y, Desai P, Scheaffer SM, et al Ipsilateral or contralateral boosting of mice with mRNA vaccines confers
equivalent immunity and protection against a SARS-CoV-2 Omicron strain.
J Virol. 2024 Aug 28:e0057424. doi: 10.1128/jvi.00574. PubMedAbstract available
ZHU J, Liu G, Sayyad Z, Goins CM, et al ISGylation of the SARS-CoV-2 N protein by HERC5 impedes N oligomerization and
thereby viral RNA synthesis.
J Virol. 2024 Aug 28:e0086924. doi: 10.1128/jvi.00869. PubMedAbstract available
TERASAKI K, Makino S Requirement of the N-terminal region of nonstructural protein 1 in cis for
SARS-CoV-2 defective RNA replication.
J Virol. 2024 Aug 28:e0090024. doi: 10.1128/jvi.00900. PubMedAbstract available
WANG G, Verma AK, Guan X, Bu F, et al Pan-beta-coronavirus subunit vaccine prevents SARS-CoV-2 Omicron, SARS-CoV, and
MERS-CoV challenge.
J Virol. 2024 Aug 27:e0037624. doi: 10.1128/jvi.00376. PubMedAbstract available
UNO N, Ebensen T, Guzman CA, Ross TM, et al Intranasal administration of octavalent next-generation influenza vaccine elicits
protective immune responses against seasonal and pre-pandemic viruses.
J Virol. 2024 Aug 22:e0035424. doi: 10.1128/jvi.00354. PubMedAbstract available
WANG L, Shi L, Liu H, Zhang J, et al Incompatible packaging signals and impaired protein functions hinder reassortment
of bat H17N10 or H18N11 segment 7 with human H1N1 influenza A viruses.
J Virol. 2024 Aug 20:e0086424. doi: 10.1128/jvi.00864. PubMedAbstract available
GAO Y, Raghavan A, Espinosa Garcia SA, Deng B, et al In vitro higher-order oligomeric assembly of the respiratory syncytial virus M2-1
protein with longer RNAs.
J Virol. 2024;98:e0104624. PubMedAbstract available
MUSA AO, Faber SR, Forrest K, Smith KP, et al Identification of distinct genotypes in circulating RSV A strains based on
variants in the virus replication-associated genes.
J Virol. 2024;98:e0099024. PubMedAbstract available
BARBOSA BOMFIM CC, Genin H, Cottoignies-Callamarte A, Gallois-Montbrun S, et al CGRP inhibits SARS-CoV-2 infection of bronchial epithelial cells, and its
pulmonary levels correlate with viral clearance in critical COVID-19 patients.
J Virol. 2024 Aug 20:e0012824. doi: 10.1128/jvi.00128. PubMedAbstract available
RHAMADIANTI AF, Abe T, Tanaka T, Ono C, et al SARS-CoV-2 papain-like protease inhibits ISGylation of the viral nucleocapsid
protein to evade host anti-viral immunity.
J Virol. 2024 Aug 9:e0085524. doi: 10.1128/jvi.00855. PubMedAbstract available
ALWINE J, Goodrum F, Banfield B, Bloom D, et al The harms of promoting the lab leak hypothesis for SARS-CoV-2 origins without
evidence.
J Virol. 2024 Aug 1:e0124024. doi: 10.1128/jvi.01240. PubMedAbstract available
July 2024
AMOAH S, Cao W, Sayedahmed EE, Wang Y, et al The frequency and function of nucleoprotein-specific CD8(+) T cells are critical
for heterosubtypic immunity against influenza virus infection.
J Virol. 2024 Jul 31:e0071124. doi: 10.1128/jvi.00711. PubMedAbstract available
WIGGINS KB, Winston SM, Reeves IL, Gaevert J, et al rAAV expressing a COBRA-designed influenza hemagglutinin generates a protective
and durable adaptive immune response with a single dose.
J Virol. 2024 Jul 30:e0078124. doi: 10.1128/jvi.00781. PubMedAbstract available
SPACKMAN E, Jones DR, McCoig AM, Colonius TJ, et al Characterization of highly pathogenic avian influenza virus in retail dairy
products in the US.
J Virol. 2024 Jul 3:e0088124. doi: 10.1128/jvi.00881. PubMedAbstract available
RICHARDSON SI, Mzindle N, Motlou T, Manamela NP, et al SARS-CoV-2 BA.4/5 infection triggers more cross-reactive FcgammaRIIIa signaling and
neutralization than BA.1, in the context of hybrid immunity.
J Virol. 2024 Jul 2:e0067824. doi: 10.1128/jvi.00678. PubMedAbstract available
June 2024
YU X, Tian J, Wang Y, Su N, et al The pseudogene GBP1P1 suppresses influenza A virus replication by acting as a
protein decoy for DHX9.
J Virol. 2024 Jun 28:e0073824. doi: 10.1128/jvi.00738. PubMedAbstract available
PECHOUS RD, Malaviarachchi PA, Banerjee SK, Byrum SD, et al An ex vivo human precision-cut lung slice platform provides insight into
SARS-CoV-2 pathogenesis and antiviral drug efficacy.
J Virol. 2024 Jun 28:e0079424. doi: 10.1128/jvi.00794. PubMedAbstract available
CHEN Z, Cui Q, Ran Y, Achi JG, et al A BSL-2 compliant mouse model of SARS-CoV-2 infection for efficient and
convenient antiviral evaluation.
J Virol. 2024 Jun 20:e0050424. doi: 10.1128/jvi.00504. PubMedAbstract available
STAHL-HENNIG C, Peter AS, Cordsmeier A, Stolte-Leeb N, et al Genetic barrier to resistance: a critical parameter for efficacy of neutralizing
monoclonal antibodies against SARS-CoV-2 in a nonhuman primate model.
J Virol. 2024 Jun 20:e0062824. doi: 10.1128/jvi.00628. PubMedAbstract available
PAN R, Li P, Meyerholz DK, Perlman S, et al Mutations in nonstructural proteins essential for pathogenicity in
SARS-CoV-2-infected mice.
J Virol. 2024 Jun 18:e0058424. doi: 10.1128/jvi.00584. PubMedAbstract available
ZHU J, Wang Z, Li Y, Zhang Z, et al Trimerized S expressed by modified vaccinia virus Ankara (MVA) confers superior
protection against lethal SARS-CoV-2 challenge in mice.
J Virol. 2024 Jun 14:e0052124. doi: 10.1128/jvi.00521. PubMedAbstract available
DAVID SC, Schaub A, Terrettaz C, Motos G, et al Stability of influenza A virus in droplets and aerosols is heightened by the
presence of commensal respiratory bacteria.
J Virol. 2024 Jun 13:e0040924. doi: 10.1128/jvi.00409. PubMedAbstract available
May 2024
HUANG Y, Owino SO, Crevar CJ, Carter DM, et al Correction for Huang et al., "N-Linked Glycans and K147 Residue on Hemagglutinin
Synergize To Elicit Broadly Reactive H1N1 Influenza Virus Antibodies".
J Virol. 2024 May 31:e0112823. doi: 10.1128/jvi.01128. PubMed
CARTER DM, Darby CA, Lefoley BC, Crevar CJ, et al Correction for Carter et al., "Design and Characterization of a Computationally
Optimized Broadly Reactive Hemagglutinin Vaccine for H1N1 Influenza Viruses".
J Virol. 2024 May 31:e0181323. doi: 10.1128/jvi.01813. PubMed
CARTER DM, Darby CA, Johnson SK, Carlock MA, et al Retraction for Carter et al., "Elicitation of Protective Antibodies against a
Broad Panel of H1N1 Viruses in Ferrets Preimmune to Historical H1N1 Influenza
Viruses".
J Virol. 2024 May 31:e0183223. doi: 10.1128/jvi.01832. PubMed
RAHMAN SM, Buchholz DW, Imbiakha B, Jager MC, et al Migraine inhibitor olcegepant reduces weight loss and IL-6 release in
SARS-CoV-2-infected older mice with neurological signs.
J Virol. 2024 May 30:e0006624. doi: 10.1128/jvi.00066. PubMedAbstract available
MARIZZI C, Ajayi PK, McMahon R, Meade PS, et al A community science approach to public health and public trust in science.
J Virol. 2024 May 29:e0082524. doi: 10.1128/jvi.00825. PubMedAbstract available
KNOLL M, Honce R, Meliopoulos V, Segredo-Otero EA, et al Host obesity impacts genetic variation in influenza A viral populations.
J Virol. 2024 May 24:e0177823. doi: 10.1128/jvi.01778. PubMedAbstract available
SCHWAB LSU, Do THT, Pilapitiya D, Koutsakos M, et al Dissemination of influenza B virus to the lower respiratory tract of mice is
restricted by the interferon response.
J Virol. 2024 May 23:e0160423. doi: 10.1128/jvi.01604. PubMedAbstract available
MA MT, Jiang Q, Chen C-H, Badeti S, et al S309-CAR-NK cells bind the Omicron variants in vitro and reduce SARS-CoV-2 viral
loads in humanized ACE2-NSG mice.
J Virol. 2024 May 20:e0003824. doi: 10.1128/jvi.00038. PubMedAbstract available
MEADE PS, Bandawane P, Bushfield K, Hoxie I, et al Detection of clade 2.3.4.4b highly pathogenic H5N1 influenza virus in New York
City.
J Virol. 2024 May 15:e0062624. doi: 10.1128/jvi.00626. PubMedAbstract available
CESAR RAMOS DE JESUS H, Solis N, Machado Y, Pablos I, et al Optimization of quenched fluorescent peptide substrates of SARS-CoV-2 3CL(pro)
main protease (Mpro) from proteomic identification of P6-P6' active site
specificity.
J Virol. 2024 May 14:e0004924. doi: 10.1128/jvi.00049. PubMedAbstract available
YU M, Li J, Gao W, Li Z, et al Multiple E3 ligases act as antiviral factors against SARS-CoV-2 via inducing the
ubiquitination and degradation of ORF9b.
J Virol. 2024 May 6:e0162423. doi: 10.1128/jvi.01624. PubMedAbstract available
April 2024
VIOX EG, Bosinger SE, Douek DC, Schreiber G, et al Harnessing the power of IFN for therapeutic approaches to COVID-19.
J Virol. 2024 Apr 23:e0120423. doi: 10.1128/jvi.01204. PubMedAbstract available
MAO D, Liu S, Phan AT, Renner S, et al The TRAF3-DYRK1A-RAD54L2 complex maintains ACE2 expression to promote SARS-CoV-2
infection.
J Virol. 2024 Apr 23:e0034724. doi: 10.1128/jvi.00347. PubMedAbstract available
HAN Y, Yuan Z, Yi Z Identification of a membrane-associated element (MAE) in the C-terminal region of
SARS-CoV-2 nsp6 that is essential for viral replication.
J Virol. 2024 Apr 19:e0034924. doi: 10.1128/jvi.00349. PubMedAbstract available
BOUGON J, Kadijk E, Gallot-Lavallee L, Curtis BA, et al Influenza A virus NS1 effector domain is required for PA-X-mediated host shutoff
in infected cells.
J Virol. 2024 Apr 17:e0190123. doi: 10.1128/jvi.01901. PubMedAbstract available
PEREZ DR A devastating blow: personal reflections on Argentina's scientific decline.
J Virol. 2024 Apr 16:e0054924. doi: 10.1128/jvi.00549. PubMedAbstract available
ISHIMARU H, Nishimura M, Shigematsu H, Marini MI, et al Epitopes of an antibody that neutralizes a wide range of SARS-CoV-2 variants in a
conserved subdomain 1 of the spike protein.
J Virol. 2024 Apr 16:e0041624. doi: 10.1128/jvi.00416. PubMedAbstract available
TAKADA K, Orba Y, Kida Y, Wu J, et al Genes involved in the limited spread of SARS-CoV-2 in the lower respiratory
airways of hamsters may be associated with adaptive evolution.
J Virol. 2024 Apr 16:e0178423. doi: 10.1128/jvi.01784. PubMedAbstract available
BU H, Zhang S, Li P, Liu Z, et al Secreted phospholipase PLA2G2E contributes to regulation of T cell immune
response against influenza virus infection.
J Virol. 2024 Apr 9:e0019824. doi: 10.1128/jvi.00198. PubMedAbstract available
BOON ACM, Bricker TL, Fritch EJ, Leist SR, et al Efficacy of host cell serine protease inhibitor MM3122 against SARS-CoV-2 for
treatment and prevention of COVID-19.
J Virol. 2024 Apr 9:e0190323. doi: 10.1128/jvi.01903. PubMedAbstract available
YANG R, Han P, Han P, Li D, et al Molecular basis of hippopotamus ACE2 binding to SARS-CoV-2.
J Virol. 2024 Apr 9:e0045124. doi: 10.1128/jvi.00451. PubMedAbstract available
XIAO X, Fu Y, You W, Huang C, et al Inhibition of the RLR signaling pathway by SARS-CoV-2 ORF7b is mediated by MAVS
and abrogated by ORF7b-homologous interfering peptide.
J Virol. 2024 Apr 4:e0157323. doi: 10.1128/jvi.01573. PubMedAbstract available
MAES A, Botzki A, Mathys J, Impens F, et al Systematic review and meta-analysis of genome-wide pooled CRISPR screens to
identify host factors involved in influenza A virus infection.
J Virol. 2024 Apr 3:e0185723. doi: 10.1128/jvi.01857. PubMedAbstract available
SILVA F, Boal-Carvalho I, Williams N, Chabert M, et al Identification of a short sequence motif in the influenza A virus pathogenicity
factor PB1-F2 required for inhibition of human NLRP3.
J Virol. 2024 Apr 3:e0041124. doi: 10.1128/jvi.00411. PubMedAbstract available
KEOWN J, Baazaoui A, Sebesta M, Stefl R, et al Structural and functional characterization of the interaction between the
influenza A virus RNA polymerase and the CTD of host RNA polymerase II.
J Virol. 2024 Apr 2:e0013824. doi: 10.1128/jvi.00138. PubMedAbstract available
BRUNET J, Choucha Z, Gransagne M, Tabbal H, et al A measles-vectored vaccine candidate expressing prefusion-stabilized SARS-CoV-2
spike protein brought to phase I/II clinical trials: candidate selection in a
preclinical murine model.
J Virol. 2024 Apr 2:e0169323. doi: 10.1128/jvi.01693. PubMedAbstract available
NAMBULLI S, Escriou N, Rennick LJ, Demers MJ, et al A measles-vectored vaccine candidate expressing prefusion-stabilized SARS-CoV-2
spike protein brought to phase I/II clinical trials: protection of African green
monkeys from COVID-19 disease.
J Virol. 2024 Apr 2:e0176223. doi: 10.1128/jvi.01762. PubMedAbstract available
March 2024
MAI F, Bergmann W, Reisinger EC, Muller-Hilke B, et al The varying extent of humoral and cellular immune responses to either vector- or
RNA-based SARS-CoV-2 vaccines persists for at least 18 months and is independent
of infection.
J Virol. 2024 Mar 19:e0191223. doi: 10.1128/jvi.01912. PubMedAbstract available
BABOT M, Boulard Y, Agouda S, Pieri L, et al Oligomeric assembly of the C-terminal and transmembrane region of SARS-CoV-2
nsp3.
J Virol. 2024 Mar 14:e0157523. doi: 10.1128/jvi.01575. PubMedAbstract available
SPRUIT CM, Palme DI, Li T, Rios Carrasco M, et al Complex N-glycans are important for interspecies transmission of H7 influenza A
viruses.
J Virol. 2024 Mar 12:e0194123. doi: 10.1128/jvi.01941. PubMedAbstract available
HEINDL MR, Rupp A-L, Schwerdtner M, Bestle D, et al ACE2 acts as a novel regulator of TMPRSS2-catalyzed proteolytic activation of
influenza A virus in airway cells.
J Virol. 2024 Mar 12:e0010224. doi: 10.1128/jvi.00102. PubMedAbstract available
WEN F, Yan Z, Chen G, Chen Y, et al Recent H9N2 avian influenza virus lost hemagglutination activity due to a K141N
substitution in hemagglutinin.
J Virol. 2024 Mar 11:e0024824. doi: 10.1128/jvi.00248. PubMedAbstract available
ZHENG T, Shen B, Bai Y, Li E, et al The PKA-CREB1 axis regulates coronavirus proliferation by viral helicase nsp13
association.
J Virol. 2024 Mar 6:e0156523. doi: 10.1128/jvi.01565. PubMedAbstract available
February 2024
ZHANG M, Liu M, Chen H, Qiu T, et al PB2 residue 473 contributes to the mammalian virulence of H7N9 avian influenza
virus by modulating viral polymerase activity via ANP32A.
J Virol. 2024 Feb 29:e0194423. doi: 10.1128/jvi.01944. PubMedAbstract available
MARTINS M, Nooruzzaman M, Cunningham JL, Ye C, et al The SARS-CoV-2 Spike is a virulence determinant and plays a major role on the
attenuated phenotype of Omicron virus in a feline model of infection.
J Virol. 2024 Feb 29:e0190223. doi: 10.1128/jvi.01902. PubMedAbstract available
HAN J, Chang W, Fang J, Hou X, et al The H9N2 avian influenza virus increases APEC adhesion to oviduct epithelia by
viral NS1 protein-mediated activation of the TGF-beta pathway.
J Virol. 2024 Feb 28:e0151223. doi: 10.1128/jvi.01512. PubMedAbstract available
UPRETY T, Yu J, Nogales A, Naveed A, et al Influenza D virus utilizes both 9-O-acetylated N-acetylneuraminic and
9-O-acetylated N-glycolylneuraminic acids as functional entry receptors.
J Virol. 2024 Feb 20:e0004224. doi: 10.1128/jvi.00042. PubMedAbstract available
NIE L, Huang Y, Cheng Z, Luo H, et al An intranasal influenza virus vector vaccine protects against Helicobacter pylori
in mice.
J Virol. 2024 Feb 15:e0192323. doi: 10.1128/jvi.01923. PubMedAbstract available
ZENG J, Du F, Xiao L, Sun H, et al Spatiotemporal genotype replacement of H5N8 avian influenza viruses contributed
to H5N1 emergence in 2021/2022 panzootic.
J Virol. 2024 Feb 15:e0140123. doi: 10.1128/jvi.01401. PubMedAbstract available
THOMAS MN, Zanella GC, Cowan B, Caceres CJ, et al Nucleoprotein reassortment enhanced transmissibility of H3 1990.4.a clade
influenza A virus in swine.
J Virol. 2024 Feb 14:e0170323. doi: 10.1128/jvi.01703. PubMedAbstract available
KATAYAMA M, Murakami S, Ishida H, Matsugo H, et al Antigenic commonality and divergence of hemagglutinin-esterase-fusion protein
among influenza D virus lineages revealed using epitope mapping.
J Virol. 2024 Feb 12:e0190823. doi: 10.1128/jvi.01908. PubMedAbstract available
VANSLAMBROUCK JM, Neil JA, Rudraraju R, Mah S, et al Kidney organoids reveal redundancy in viral entry pathways during ACE2-dependent
SARS-CoV-2 infection.
J Virol. 2024 Feb 9:e0180223. doi: 10.1128/jvi.01802. PubMedAbstract available
SHINGAI M, Iida S, Kawai N, Kawahara M, et al Extraction of the CDRH3 sequence of the mouse antibody repertoire selected upon
influenza virus infection by subtraction of the background antibody repertoire.
J Virol. 2024 Feb 7:e0199523. doi: 10.1128/jvi.01995. PubMedAbstract available
YANG Q, Barbachano-Guerrero A, Fairchild LM, Rowland TJ, et al Macrophages derived from human induced pluripotent stem cells (iPSCs) serve as a
high-fidelity cellular model for investigating HIV-1, dengue, and influenza
viruses.
J Virol. 2024 Feb 7:e0156323. doi: 10.1128/jvi.01563. PubMedAbstract available
LI H, Sun H, Tao M, Han Q, et al Recombinant parainfluenza virus 5 expressing clade 2.3.4.4b H5 hemagglutinin
protein confers broad protection against H5Ny influenza viruses.
J Virol. 2024 Feb 2:e0112923. doi: 10.1128/jvi.01129. PubMedAbstract available
NIU S, Zhao Z, Liu Z, Rong X, et al Structural basis and analysis of hamster ACE2 binding to different SARS-CoV-2
spike RBDs.
J Virol. 2024 Feb 2:e0115723. doi: 10.1128/jvi.01157. PubMedAbstract available
BRICKER TL, Joshi A, Soudani N, Scheaffer SM, et al Prototype and BA.5 protein nanoparticle vaccines protect against Omicron BA.5
variant in Syrian hamsters.
J Virol. 2024 Feb 2:e0120623. doi: 10.1128/jvi.01206. PubMedAbstract available
HSIEH M-S, Hsu C-W, Liao H-C, Lin C-L, et al SARS-CoV-2 spike-FLIPr fusion protein plus lipidated FLIPr protects against
various SARS-CoV-2 variants in hamsters.
J Virol. 2024 Feb 1:e0154623. doi: 10.1128/jvi.01546. PubMedAbstract available
January 2024
ROWE T, Davis W, Wentworth DE, Ross T, et al Differential interferon responses to influenza A and B viruses in primary ferret
respiratory epithelial cells.
J Virol. 2024 Jan 31:e0149423. doi: 10.1128/jvi.01494. PubMedAbstract available
SHEN S, Guo H, Li Y, Zhang L, et al SARS-CoV-2 and oncolytic EV-D68-encoded proteases differentially regulate
pyroptosis.
J Virol. 2024 Jan 30:e0190923. doi: 10.1128/jvi.01909. PubMedAbstract available
KIERAN TJ, Sun X, Maines TR, Beauchemin CAA, et al Exploring associations between viral titer measurements and disease outcomes in
ferrets inoculated with 125 contemporary influenza A viruses.
J Virol. 2024 Jan 19:e0166123. doi: 10.1128/jvi.01661. PubMedAbstract available
DULIN H, Barre RS, Xu D, Neal A, et al Harnessing preexisting influenza virus-specific immunity increases antibody
responses against SARS-CoV-2.
J Virol. 2024 Jan 11:e0157123. doi: 10.1128/jvi.01571. PubMedAbstract available
HE Y, Guo Z, Subiaur S, Benegal A, et al Antibody inhibition of influenza A virus assembly and release.
J Virol. 2024 Jan 5:e0139823. doi: 10.1128/jvi.01398. PubMedAbstract available
DEY S, Mondal A Unveiling the role of host kinases at different steps of influenza A virus life
cycle.
J Virol. 2024 Jan 4:e0119223. doi: 10.1128/jvi.01192. PubMedAbstract available
FARJO M, Koelle K, Martin MA, Gibson LL, et al Within-host evolutionary dynamics and tissue compartmentalization during acute
SARS-CoV-2 infection.
J Virol. 2024 Jan 4:e0161823. doi: 10.1128/jvi.01618. PubMedAbstract available
LI K, Verma A, Li P, Ortiz ME, et al Adaptation of SARS-CoV-2 to ACE2(H353K) mice reveals new spike residues that
drive mouse infection.
J Virol. 2024 Jan 3:e0151023. doi: 10.1128/jvi.01510. PubMedAbstract available
RASMUSSEN AL, Gronvall GK, Lowen AC, Goodrum F, et al Virology-the path forward.
J Virol. 2024 Jan 3:e0179123. doi: 10.1128/jvi.01791. PubMedAbstract available
December 2023
BOLLAND W, Michel V, Planas D, Hubert M, et al High fusion and cytopathy of SARS-CoV-2 variant B.1.640.1.
J Virol. 2023 Dec 13:e0135123. doi: 10.1128/jvi.01351. PubMedAbstract available
JERONIMO PMC, Aksenen CF, Duarte IO, Lins RD, et al Evolutionary deletions within the SARS-CoV-2 genome as signature trends for virus
fitness and adaptation.
J Virol. 2023 Dec 13:e0140423. doi: 10.1128/jvi.01404. PubMedAbstract available
ZHANG L, Shao Y, Wang Y, Yang Q, et al Twenty natural amino acid substitution screening at the last residue 121 of
influenza A virus NS2 protein reveals the critical role of NS2 in promoting virus
genome replication by coordinating with viral polymerase.
J Virol. 2023 Dec 6:e0116623. doi: 10.1128/jvi.01166. PubMedAbstract available
PHAM TX, Huynh TTX, Choi J, Lee J-B, et al SARS-CoV-2 exploits cellular RAD51 to promote viral propagation: implication of
RAD51 inhibitor as a potential drug candidate against COVID-19.
J Virol. 2023 Dec 5:e0173723. doi: 10.1128/jvi.01737. PubMedAbstract available
ZAYOU L, Prakash S, Dhanushkodi NR, Quadiri A, et al A multi-epitope/CXCL11 prime/pull coronavirus mucosal vaccine boosts the
frequency and the function of lung-resident memory CD4(+) and CD8(+) T cells and
enhanced protection against COVID-19-like symptoms and death caused by SARS-CoV-2
infection.
J Virol. 2023 Dec 1:e0109623. doi: 10.1128/jvi.01096. PubMedAbstract available
November 2023
LI K, Huntwork RHC, Horn GQ, Abraha M, et al Cryptic-site-specific antibodies to the SARS-CoV-2 receptor binding domain can
retain functional binding affinity to spike variants.
J Virol. 2023 Nov 29:e0107023. doi: 10.1128/jvi.01070. PubMedAbstract available
DOMINGO E, Martinez-Gonzalez B, Garcia-Crespo C, Somovilla P, et al Puzzles, challenges, and information reservoir of SARS-CoV-2 quasispecies.
J Virol. 2023 Nov 21:e0151123. doi: 10.1128/jvi.01511. PubMedAbstract available
BRAGAZZI CUNHA J, Leix K, Sherman EJ, Mirabelli C, et al Type I interferon signaling induces a delayed antiproliferative response in
respiratory epithelial cells during SARS-CoV-2 infection.
J Virol. 2023 Nov 17:e0127623. doi: 10.1128/jvi.01276. PubMedAbstract available
ALRUWAILI M, Armstrong S, Prince T, Erdmann M, et al SARS-CoV-2 NSP12 associates with TRiC and the P323L substitution acts as a host
adaption.
J Virol. 2023 Nov 6:e0042423. doi: 10.1128/jvi.00424. PubMedAbstract available
SUN W, Xu J, Wang Z, Li D, et al Clade 2.3.4.4 H5 chimeric cold-adapted attenuated influenza vaccines induced
cross-reactive protection in mice and ferrets.
J Virol. 2023 Nov 2:e0110123. doi: 10.1128/jvi.01101. PubMedAbstract available
RIJNINK WF, Stadlbauer D, Puente-Massaguer E, Okba NMA, et al Characterization of non-neutralizing human monoclonal antibodies that target the
M1 and NP of influenza A viruses.
J Virol. 2023 Nov 2:e0164622. doi: 10.1128/jvi.01646. PubMedAbstract available
October 2023
PAHMEIER F, Lavacca T-M, Goellner S, Neufeldt CJ, et al Identification of host dependency factors involved in SARS-CoV-2 replication
organelle formation through proteomics and ultrastructural analysis.
J Virol. 2023 Oct 31:e0087823. doi: 10.1128/jvi.00878. PubMedAbstract available
CAO J, Shi M, Zhu L, Li X, et al The matrix protein of respiratory syncytial virus suppresses interferon signaling
via RACK1 association.
J Virol. 2023;97:e0074723. PubMedAbstract available
BARTSCH YC, Cizmeci D, Yuan D, Mehta N, et al Vaccine-induced antibody Fc-effector functions in humans immunized with a
combination Ad26.RSV.preF/RSV preF protein vaccine.
J Virol. 2023 Oct 30:e0077123. doi: 10.1128/jvi.00771. PubMedAbstract available
LI Y, Arcos S, Sabsay KR, Te Velthuis AJW, et al Deep mutational scanning reveals the functional constraints and evolutionary
potential of the influenza A virus PB1 protein.
J Virol. 2023 Oct 26:e0132923. doi: 10.1128/jvi.01329. PubMedAbstract available
YAN Z, Li Y, Huang S, Wen F, et al Global distribution, receptor binding, and cross-species transmission of H6
influenza viruses: risks and implications for humans.
J Virol. 2023 Oct 25:e0137023. doi: 10.1128/jvi.01370. PubMedAbstract available
UNDI RB, Ahsan N, Larabee JL, Darlene-Reuter N, et al Blocking of doublecortin-like kinase 1-regulated SARS-CoV-2 replication cycle
restores cell signaling network.
J Virol. 2023 Oct 20:e0119423. doi: 10.1128/jvi.01194. PubMedAbstract available
KUMAR S, Delipan R, Chakraborty D, Kanjo K, et al Mutations in S2 subunit of SARS-CoV-2 Omicron spike strongly influence its
conformation, fusogenicity, and neutralization sensitivity.
J Virol. 2023 Oct 20:e0092223. doi: 10.1128/jvi.00922. PubMedAbstract available
YE G, Pan R, Bu F, Zheng J, et al Discovery of Nanosota-2, -3, and -4 as super potent and broad-spectrum
therapeutic nanobody candidates against COVID-19.
J Virol. 2023 Oct 19:e0144823. doi: 10.1128/jvi.01448. PubMedAbstract available
SUN H, Wang Y, Chen X, Jiang Y, et al Structural basis for broad neutralization of human antibody against Omicron
sublineages and evasion by XBB variant.
J Virol. 2023 Oct 19:e0113723. doi: 10.1128/jvi.01137. PubMedAbstract available
JOHNSON RM, Ardanuy J, Hammond H, Logue J, et al Diet-induced obesity and diabetes enhance mortality and reduce vaccine efficacy
for SARS-CoV-2.
J Virol. 2023 Oct 17:e0133623. doi: 10.1128/jvi.01336. PubMedAbstract available
LIANG CY, Huang I, Han J, Sownthirarajan B, et al Avian influenza A viruses exhibit plasticity in sialylglycoconjugate receptor
usage in human lung cells.
J Virol. 2023 Oct 16:e0090623. doi: 10.1128/jvi.00906. PubMedAbstract available
WU Y, Shi J, He X, Lu J, et al Protection of the receptor binding domain (RBD) dimer against SARS-CoV-2 and its
variants.
J Virol. 2023 Oct 16:e0127923. doi: 10.1128/jvi.01279. PubMedAbstract available
MISPLON JA, Lo CY, Crabbs TA, Price GE, et al Adenoviral-vectored universal influenza vaccines administered intranasally reduce
lung inflammatory responses upon viral challenge 15 months post-vaccination.
J Virol. 2023 Oct 13:e0067423. doi: 10.1128/jvi.00674. PubMedAbstract available
MIURA K, Suzuki Y, Ishida K, Arakawa M, et al Distinct motifs in the E protein are required for SARS-CoV-2 virus particle
formation and lysosomal deacidification in host cells.
J Virol. 2023 Oct 13:e0042623. doi: 10.1128/jvi.00426. PubMedAbstract available
MAHE D, Bourgeau S, da Silva J, Schlederer J, et al SARS-CoV-2 replicates in the human testis with slow kinetics and has no major
deleterious effects ex vivo.
J Virol. 2023 Oct 13:e0110423. doi: 10.1128/jvi.01104. PubMedAbstract available
RIBO-MOLINA P, Weiss HJ, Susma B, van Nieuwkoop S, et al 4-Octyl itaconate reduces influenza A replication by targeting the nuclear export
protein CRM1.
J Virol. 2023 Oct 12:e0132523. doi: 10.1128/jvi.01325. PubMedAbstract available
ISELI AN, Pohl MO, Glas I, Gaggioli E, et al The neuraminidase activity of influenza A virus determines the strain-specific
sensitivity to neutralization by respiratory mucus.
J Virol. 2023 Oct 11:e0127123. doi: 10.1128/jvi.01271. PubMedAbstract available
GIRARD J, Jakob C, Toews LK, Fuchs J, et al Disruption of influenza virus packaging signals results in various misassembled
genome complexes.
J Virol. 2023 Oct 9:e0107623. doi: 10.1128/jvi.01076. PubMedAbstract available
CARNACCINI S, Caceres CJ, Gay LC, Ferreri LM, et al Antigenic mapping of the hemagglutinin of the H9 subtype influenza A viruses
using sera from Japanese quail (Coturnix c. japonica).
J Virol. 2023 Oct 6:e0074323. doi: 10.1128/jvi.00743. PubMedAbstract available
MCMAHON M, Tan J, O'Dell G, Kirkpatrick Roubidoux E, et al Immunity induced by vaccination with recombinant influenza B virus neuraminidase
protein breaks viral transmission chains in guinea pigs in an exposure
intensity-dependent manner.
J Virol. 2023 Oct 6:e0105723. doi: 10.1128/jvi.01057. PubMedAbstract available
KIMURA I, Yamasoba D, Nasser H, Ito H, et al Multiple mutations of SARS-CoV-2 Omicron BA.2 variant orchestrate its virological
characteristics.
J Virol. 2023 Oct 5:e0101123. doi: 10.1128/jvi.01011. PubMedAbstract available
MENG X, Veit M Palmitoylation of the hemagglutinin of influenza B virus by ER-localized DHHC
enzymes 1, 2, 4, and 6 is required for efficient virus replication.
J Virol. 2023 Oct 4:e0124523. doi: 10.1128/jvi.01245. PubMedAbstract available
September 2023
ZHAO Y, Sui L, Wu P, Li L, et al EGR1 functions as a new host restriction factor for SARS-CoV-2 to inhibit virus
replication through the E3 ubiquitin ligase MARCH8.
J Virol. 2023 Sep 29:e0102823. doi: 10.1128/jvi.01028. PubMedAbstract available
LI J, Gui Q, Liang FX, Sall J, et al The REEP5/TRAM1 complex binds SARS-CoV-2 NSP3 and promotes virus replication.
J Virol. 2023 Sep 28:e0050723. doi: 10.1128/jvi.00507. PubMedAbstract available
NENNA R, Stern DA, Carr TF, Spangenberg A, et al Prenatal exposure to RSV season influences first-year risk of RSV lower
respiratory illness and RSV-specific immune responses assessed at birth.
J Virol. 2023;97:e0076723. PubMedAbstract available
WALLACE LE, de Vries E, van Kuppeveld FJM, de Haan CAM, et al Neuraminidase-dependent entry of influenza A virus is determined by hemagglutinin
receptor-binding specificity.
J Virol. 2023 Sep 27:e0060223. doi: 10.1128/jvi.00602. PubMedAbstract available
MCCOOL RS, Musayev M, Bush SM, Derrien-Colemyn A, et al Vaccination with prefusion-stabilized respiratory syncytial virus fusion protein
elicits antibodies targeting a membrane-proximal epitope.
J Virol. 2023 Sep 22:e0092923. doi: 10.1128/jvi.00929. PubMedAbstract available
SCHOEN A, Holzer M, Muller MA, Wallerang KB, et al Functional comparisons of the virus sensor RIG-I from humans, the microbat Myotis
daubentonii, and the megabat Rousettus aegyptiacus, and their response to
SARS-CoV-2 infection.
J Virol. 2023 Sep 20:e0020523. doi: 10.1128/jvi.00205. PubMedAbstract available
FUJITA S, Kosugi Y, Kimura I, Tokunaga K, et al Determination of the factors responsible for the tropism of SARS-CoV-2-related
bat coronaviruses to Rhinolophus bat ACE2.
J Virol. 2023 Sep 19:e0099023. doi: 10.1128/jvi.00990. PubMedAbstract available
XING M, Wang Y, Wang X, Liu J, et al Broad-spectrum vaccine via combined immunization routes triggers potent immunity
to SARS-CoV-2 and its variants.
J Virol. 2023 Sep 14:e0072423. doi: 10.1128/jvi.00724. PubMedAbstract available
CASE JB, Scheaffer SM, Darling TL, Bricker TL, et al Characterization of the SARS-CoV-2 BA.5.5 and BQ.1.1 Omicron variants in mice and
hamsters.
J Virol. 2023 Sep 7:e0062823. doi: 10.1128/jvi.00628. PubMedAbstract available
August 2023
LIN HF, Liu MQ, Jiang RD, Gong QC, et al Characterization of a mouse-adapted strain of bat severe acute respiratory
syndrome-related coronavirus.
J Virol. 2023 Aug 21:e0079023. doi: 10.1128/jvi.00790. PubMedAbstract available
LEONARD RA, Rao VN, Bartlett A, Froggatt HM, et al A low-background, fluorescent assay to evaluate inhibitors of diverse viral
proteases.
J Virol. 2023 Aug 14:e0059723. doi: 10.1128/jvi.00597. PubMedAbstract available
JIN H, Cheng L, Gong Y, Zhu Y, et al Design of a bifunctional pan-sarbecovirus entry inhibitor targeting the cell
receptor and viral fusion protein.
J Virol. 2023 Aug 14:e0019223. doi: 10.1128/jvi.00192. PubMedAbstract available
ZHANG W, Shi K, Geng Q, Herbst M, et al Structural evolution of SARS-CoV-2 omicron in human receptor recognition.
J Virol. 2023 Aug 14:e0082223. doi: 10.1128/jvi.00822. PubMedAbstract available
LLEWELLYN GN, Chen HY, Rogers GL, Huang X, et al Comparison of SARS-CoV-2 entry inhibitors based on ACE2 receptor or engineered
Spike-binding peptides.
J Virol. 2023 Aug 9:e0068423. doi: 10.1128/jvi.00684. PubMedAbstract available
MYKYTYN AZ, Breugem TI, Geurts MH, Beumer J, et al SARS-CoV-2 Omicron entry is type II transmembrane serine protease-mediated in
human airway and intestinal organoid models.
J Virol. 2023 Aug 9:e0085123. doi: 10.1128/jvi.00851. PubMedAbstract available
THOMPSON D, Cismaru CV, Rougier JS, Schwemmle M, et al The M2 proteins of bat influenza A viruses reveal atypical features compared to
conventional M2 proteins.
J Virol. 2023 Aug 4:e0038823. doi: 10.1128/jvi.00388. PubMedAbstract available
July 2023
TALUKDAR SN, McGregor B, Osan JK, Hur J, et al Respiratory Syncytial Virus Infection Does Not Induce Epithelial-Mesenchymal
Transition.
J Virol. 2023;97:e0039423. PubMedAbstract available
HICKERSON BT, Petrovskaya SN, Dickensheets H, Donnelly RP, et al Impact of Baloxavir Resistance-Associated Substitutions on Influenza Virus Growth
and Drug Susceptibility.
J Virol. 2023 Jul 5:e0015423. doi: 10.1128/jvi.00154. PubMedAbstract available
JENSEN JL, Sankhala RS, Dussupt V, Bai H, et al Targeting the Spike Receptor Binding Domain Class V Cryptic Epitope by an
Antibody with Pan-Sarbecovirus Activity.
J Virol. 2023 Jul 3:e0159622. doi: 10.1128/jvi.01596. PubMedAbstract available
June 2023
HUANG J, Chen Z, Ye Y, Shao Y, et al DTX3L Enhances Type I Interferon Antiviral Response by Promoting the
Ubiquitination and Phosphorylation of TBK1.
J Virol. 2023;97:e0068723. PubMedAbstract available
YANG X, Duan H, Liu X, Zhang X, et al Broad Sarbecovirus Neutralizing Antibodies Obtained by Computational Design and
Synthetic Library Screening.
J Virol. 2023 Jun 27:e0061023. doi: 10.1128/jvi.00610. PubMedAbstract available
TERASAKI K, Narayanan K, Makino S Identification of a 1.4-kb-Long Sequence Located in the nsp12 and nsp13 Coding
Regions of SARS-CoV-2 Genomic RNA That Mediates Efficient Viral RNA Packaging.
J Virol. 2023 Jun 27:e0065923. doi: 10.1128/jvi.00659. PubMedAbstract available
LI A, Zhang B, Zhao K, Yin Z, et al SARS-CoV-2 nsp13 Restricts Episomal DNA Transcription without Affecting
Chromosomal DNA.
J Virol. 2023 Jun 22:e0051223. doi: 10.1128/jvi.00512. PubMedAbstract available
GOFFIN E, Du X, Hemmi S, Machiels B, et al A Single Oral Immunization with a Replication-Competent Adenovirus-Vectored
Vaccine Protects Mice from Influenza Respiratory Infection.
J Virol. 2023 Jun 20:e0013523. doi: 10.1128/jvi.00135. PubMedAbstract available
CHEN P, Jin Z, Peng L, Zheng Z, et al Characterization of an Emergent Chicken H3N8 Influenza Virus in Southern China: a
Potential Threat to Public Health.
J Virol. 2023 Jun 8:e0043423. doi: 10.1128/jvi.00434. PubMedAbstract available
ZHENG H, Ma L, Gui R, Lin X, et al Correction for Zheng et al., "G Protein Subunit beta1 Facilitates Influenza A Virus
Replication by Promoting the Nuclear Import of PB2".
J Virol. 2023 Jun 6:e0054623. doi: 10.1128/jvi.00546. PubMed
May 2023
WANG C, Honce R, Salvatore M, Chow D, et al Influenza Defective Interfering Virus Promotes Multiciliated Cell Differentiation
and Reduces the Inflammatory Response in Mice.
J Virol. 2023 May 31:e0049323. doi: 10.1128/jvi.00493. PubMedAbstract available
RUNSTADLER JA, Lowen AC, Kayali G, Tompkins SM, et al Field Research Is Essential to Counter Virological Threats.
J Virol. 2023;97:e0054423. PubMedAbstract available
REZENDE W, Ye X, Angelo LS, Carisey AF, et al The Efficiency of p27 Cleavage during In Vitro Respiratory Syncytial Virus (RSV)
Infection Is Cell Line and RSV Subtype Dependent.
J Virol. 2023;97:e0025423. PubMedAbstract available
SREENIVASAN CC, Liu R, Gao R, Guo Y, et al Influenza C and D Viruses Demonstrated a Differential Respiratory Tissue Tropism
in a Comparative Pathogenesis Study in Guinea Pigs.
J Virol. 2023 May 18:e0035623. doi: 10.1128/jvi.00356. PubMedAbstract available
JIANG H, Joshi A, Gan T, Janowski AB, et al The Highly Conserved Stem-Loop II Motif Is Dispensable for SARS-CoV-2.
J Virol. 2023 May 18:e0063523. doi: 10.1128/jvi.00635. PubMedAbstract available
SLANINA H, Madhugiri R, Wenk K, Reinke T, et al Conserved Characteristics of NMPylation Activities of Alpha- and Betacoronavirus
NiRAN Domains.
J Virol. 2023 May 18:e0046523. doi: 10.1128/jvi.00465. PubMedAbstract available
ISHIMARU H, Nishimura M, Tjan LH, Sutandhio S, et al Identification and Analysis of Monoclonal Antibodies with Neutralizing Activity
against Diverse SARS-CoV-2 Variants.
J Virol. 2023 May 16:e0028623. doi: 10.1128/jvi.00286. PubMedAbstract available
ZHANG L, Wang Y, Shao Y, Guo J, et al Fine Regulation of Influenza Virus RNA Transcription and Replication by
Stoichiometric Changes in Viral NS1 and NS2 Proteins.
J Virol. 2023 May 11:e0033723. doi: 10.1128/jvi.00337. PubMedAbstract available
SENGAR A, Cervantes M, Bondalapati ST, Hess T, et al Single-Virus Fusion Measurements Reveal Multiple Mechanistically Equivalent
Pathways for SARS-CoV-2 Entry.
J Virol. 2023 May 3:e0199222. doi: 10.1128/jvi.01992. PubMedAbstract available
April 2023
SPECK P, Mackenzie J, Bull RA, Slobedman B, et al Statement in Support of: "Virology under the Microscope-a Call for Rational
Discourse".
J Virol. 2023 Apr 25:e0045123. doi: 10.1128/jvi.00451. PubMed
PEACOCK TP, Sheppard CM, Lister MG, Staller E, et al Mammalian ANP32A and ANP32B Proteins Drive Differential Polymerase Adaptations in
Avian Influenza Virus.
J Virol. 2023 Apr 19:e0021323. doi: 10.1128/jvi.00213. PubMedAbstract available
KETTUNEN P, Lesnikova A, Rasanen N, Ojha R, et al SARS-CoV-2 Infection of Human Neurons Is TMPRSS2 Independent, Requires Endosomal
Cell Entry, and Can Be Blocked by Inhibitors of Host Phosphoinositol-5 Kinase.
J Virol. 2023 Apr 11:e0014423. doi: 10.1128/jvi.00144. PubMedAbstract available
LIN SJ, Lin KM, Chen SJ, Ku CC, et al Type I Interferon Orchestrates Demand-Adapted Monopoiesis during Influenza A
Virus Infection via STAT1-Mediated Upregulation of Macrophage Colony-Stimulating
Factor Receptor Expression.
J Virol. 2023 Apr 6:e0010223. doi: 10.1128/jvi.00102. PubMedAbstract available
March 2023
TAN Y, Shilts MH, Rosas-Salazar C, Puri V, et al Influence of Sex on Respiratory Syncytial Virus Genotype Infection Frequency and
Nasopharyngeal Microbiome.
J Virol. 2023;97:e0147222. PubMedAbstract available
ALWINE JC, Casadevall A, Enquist LW, Goodrum FD, et al A critical analysis of the evidence for the SARS-CoV-2 origin hypotheses.
J Virol. 2023 Mar 10:e0036523. doi: 10.1128/jvi.00365. PubMedAbstract available
WANG X, Wang W, Wang T, Wang J, et al SARS-CoV-2 ORF8 Protein Induces Endoplasmic Reticulum Stress-like Responses and
Facilitates Virus Replication by Triggering Calnexin: an Unbiased Study.
J Virol. 2023 Mar 6:e0001123. doi: 10.1128/jvi.00011. PubMedAbstract available
MOLS VC, Lamers MM, Leijten LM, Breugem TI, et al Intestinal Tropism of a Betacoronavirus (Merbecovirus) in Nathusius's Pipistrelle
Bat (Pipistrellus nathusii), Its Natural Host.
J Virol. 2023 Mar 1:e0009923. doi: 10.1128/jvi.00099. PubMedAbstract available
February 2023
FROLOV I, Agback T, Palchevska O, Dominguez F, et al All Domains of SARS-CoV-2 nsp1 Determine Translational Shutoff and Cytotoxicity
of the Protein.
J Virol. 2023 Feb 27:e0186522. doi: 10.1128/jvi.01865. PubMedAbstract available
ZHANG L, Hom N, Ojha A, Lovendahl KN, et al Cytoplasmic Tail Truncation Stabilizes S1-S2 Association and Enhances S Protein
Incorporation into SARS-CoV-2 Pseudovirions.
J Virol. 2023 Feb 15:e0165022. doi: 10.1128/jvi.01650. PubMedAbstract available
WANG X, Wen Z, Cao H, Luo J, et al Transferrin Receptor Protein 1 Cooperates with mGluR2 To Mediate the
Internalization of Rabies Virus and SARS-CoV-2.
J Virol. 2023 Feb 13:e0161122. doi: 10.1128/jvi.01611. PubMedAbstract available
WANG Y, Ge F, Wang J, Li H, et al Mycobacterium bovis BCG Given at Birth Followed by Inactivated Respiratory
Syncytial Virus Vaccine Prevents Vaccine-Enhanced Disease by Promoting Trained
Macrophages and Resident Memory T Cells.
J Virol. 2023 Feb 13:e0176422. doi: 10.1128/jvi.01764. PubMedAbstract available
AMANAT F, Clark J, Carreno JM, Strohmeier S, et al Immunity to Seasonal Coronavirus Spike Proteins Does Not Protect from SARS-CoV-2
Challenge in a Mouse Model but Has No Detrimental Effect on Protection Mediated
by COVID-19 mRNA Vaccination.
J Virol. 2023 Feb 13:e0166422. doi: 10.1128/jvi.01664. PubMedAbstract available
BEI C, Zhang C, Wu H, Feng H, et al DDX3X Is Hijacked by Snakehead Vesiculovirus Phosphoprotein To Facilitate Virus
Replication via Stabilization of the Phosphoprotein.
J Virol. 2023 Feb 6:e0003523. doi: 10.1128/jvi.00035. PubMedAbstract available
SCHINDEWOLF C, Lokugamage K, Vu MN, Johnson BA, et al SARS-CoV-2 Uses Nonstructural Protein 16 To Evade Restriction by IFIT1 and IFIT3.
J Virol. 2023 Feb 1:e0153222. doi: 10.1128/jvi.01532. PubMedAbstract available
January 2023
GOODRUM F, Lowen A, Lakdawala S, Alwine J, et al Virology under the Microscope-a Call for Rational Discourse.
J Virol. 2023 Jan 26:e0008923. doi: 10.1128/jvi.00089. PubMedAbstract available
LIU MQ, Lin HF, Li J, Chen Y, et al A SARS-CoV-2-Related Virus from Malayan Pangolin Causes Lung Infection without
Severe Disease in Human ACE2-Transgenic Mice.
J Virol. 2023 Jan 23:e0171922. doi: 10.1128/jvi.01719. PubMedAbstract available
RAJAGOPALA SV, Strickland BA, Pakala SB, Kimura KS, et al Mucosal Gene Expression in Response to SARS-CoV-2 Is Associated with Viral Load.
J Virol. 2023 Jan 19:e0147822. doi: 10.1128/jvi.01478. PubMedAbstract available
MA J, Liu X, Zhou M, Chen P, et al A Heterologous Challenge Rescues the Attenuated Immunogenicity of SARS-CoV-2
Omicron BA.1 Variant in Syrian Hamster Model.
J Virol. 2023 Jan 18:e0168422. doi: 10.1128/jvi.01684. PubMedAbstract available
September 2021
TANG W, Li Y, Song Q, Wang Z, et al Mechanism of Cross-Resistance to Fusion Inhibitors Conferred by the K394R
Mutation in Respiratory Syncytial Virus Fusion Protein.
J Virol. 2021;95:e0120521. PubMedAbstract available